![Mark Bach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Bach
Inga fler pågående positioner
Förmögenhet: 69 171 $ per 2026-07-31
Profil
Mark A. Bach served as the Chief Executive Officer at Accumulus Synergy, Inc from 2019 to 2020.
Prior to that, he held the position of VP-Clinical Research Operations Worldwide at Merck & Co., Inc. from 1993 to 2010.
From 2014 to 2019, he worked as the Head-Asia Pacific Medical Sciences at Janssen Pharmaceuticals, Inc. He also served as the Vice President-Research & Development at Janssen Pharmaceutical KK from 2010 to 2012.
Additionally, he held the position of Senior Vice President-Clinical Development at Ascendis Pharma A. Currently, he is working as the Chief Medical Officer at Structure Therapeutics, Inc. Dr. Bach completed his undergraduate studies at Carleton College and obtained a doctorate degree from both The University of Chicago and Baylor College of Medicine.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2024-03-15 | 4 320 ( 0 % ) | 69 171 $ | 2026-07-31 |
Tidigare kända positioner av Mark Bach
| Företag | Position | Slut |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-09-18 |
Accumulus Synergy, Inc
 Accumulus Synergy, Inc Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit industry association | Verkställande Direktör | 2020-10-01 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Företagsledare/Principal | 2019-08-01 |
Janssen Pharmaceutical KK
 Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets prescription pharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | 2012-11-01 |
| MERCK & CO., INC. | Företagsledare/Principal | 2010-01-01 |
Mark Bachs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
92
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Janssen Pharmaceutical KK
Janssen Pharmaceutical KK Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets prescription pharmaceutical products | Health Technology |
Carleton College
 Carleton College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Accumulus Synergy, Inc
Accumulus Synergy, Inc Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit industry association | Commercial Services |
